HDAC inhibitors tested in phase III trial
Nat Rev Clin Oncol
.
2019 Aug;16(8):465.
doi: 10.1038/s41571-019-0224-2.
Author
Diana Romero
1
Affiliation
1
Nature Reviews Clinical Oncology, . nrclinonc@nature.com.
PMID:
31076738
DOI:
10.1038/s41571-019-0224-2
No abstract available
Publication types
Comment
MeSH terms
Androstadienes
Breast Neoplasms*
Double-Blind Method
Histone Deacetylase Inhibitors*
Humans
Postmenopause
Substances
Androstadienes
Histone Deacetylase Inhibitors
exemestane